Ohcanbohtosat - C. Chouaïd

Aiddostahte ozu
  1. 1
    Variability of the chronic obstructive pulmonary disease key epidemiological data in Europe: systematic review

    Variability of the chronic obstructive pulmonary disease key epidemiological data in Europe: systematic review Dahkki Kokuvi Atsou, C. Chouaïd, Gilles Hejblum

    Almmustuhtton 2011
    Viečča ollesdeavstta Viečča ollesdeavstta
    Revisão
    Lasit oiddohiidda
    Furkejuvvon:
  2. 2
    ROS-1 Fusions in Non-Small-Cell Lung Cancer: Evidence to Date

    ROS-1 Fusions in Non-Small-Cell Lung Cancer: Evidence to Date Dahkki S. Gendarme, Olivier Bylicki, C. Chouaïd, Florian Guisier

    Almmustuhtton 2022
    Viečča ollesdeavstta Viečča ollesdeavstta
    Revisão
    Lasit oiddohiidda
    Furkejuvvon:
  3. 3
    Papillon trial, a major advance in the management of patients with metastatic, mutated-EGFR exon 20 insertion non-small-cell lung cancer

    Papillon trial, a major advance in the management of patients with metastatic, mutated-EGFR exon 20 insertion non-small-cell lung cancer Dahkki C. Chouaïd, Jean‐Baptiste Assié, J.B. Auliac

    Almmustuhtton 2025
    Viečča ollesdeavstta
    Artigo
    Lasit oiddohiidda
    Furkejuvvon:
  4. 4
    Delays for diagnosis and treatment of lung cancers: a systematic review

    Delays for diagnosis and treatment of lung cancers: a systematic review Dahkki F. Viñas, I. Ben Hassen, L. Jabot, I. Monnet, C. Chouaïd

    Almmustuhtton 2014
    Viečča ollesdeavstta Viečča ollesdeavstta
    Revisão
    Lasit oiddohiidda
    Furkejuvvon:
  5. 5
    Lung cancer and end-of-life care: a systematic review and thematic synthesis of aggressive inpatient care

    Lung cancer and end-of-life care: a systematic review and thematic synthesis of aggressive inpatient care Dahkki Olivier Bylicki, Morgane Didier, F. Rivière, J. Margery, F. Grassin, C. Chouaïd

    Almmustuhtton 2019
    Viečča ollesdeavstta Viečča ollesdeavstta
    Revisão
    Lasit oiddohiidda
    Furkejuvvon:
  6. 6
    Frequency of comorbidities in chronic obstructive pulmonary disease, and impact on all-cause mortality: A population-based cohort study

    Frequency of comorbidities in chronic obstructive pulmonary disease, and impact on all-cause mortality: A population-based cohort study Dahkki Laurent Laforest, Nicolás Roche, Gilles Devouassoux, Manon Belhassen, C. Chouaïd, M. Ginoux, Éric Van Ganse

    Almmustuhtton 2016
    Viečča ollesdeavstta Viečča ollesdeavstta
    Artigo
    Lasit oiddohiidda
    Furkejuvvon:
  7. 7
    Lung cancer and interstitial lung disease: a literature review

    Lung cancer and interstitial lung disease: a literature review Dahkki Jean‐Marc Naccache, Q. Gibiot, I. Monnet, Martine Antoine, Marie Wislez, C. Chouaïd, Jacques Cadranel

    Almmustuhtton 2018
    Viečča ollesdeavstta
    Revisão
    Lasit oiddohiidda
    Furkejuvvon:
  8. 8
    Cost-effectiveness analysis of pembrolizumab versus standard-of-care chemotherapy for first-line treatment of PD-L1 positive (>50%) metastatic squamous and non-squamous non-small cell lung cancer in France

    Cost-effectiveness analysis of pembrolizumab versus standard-of-care chemotherapy for first-line treatment of PD-L1 positive (>50%) metastatic squamous and non-squamous non-smal... Dahkki C. Chouaïd, L. Bensimon, E. Clay, A. Millier, L. Lévy-Bachelot, Min Huang, Pierre Lévy

    Almmustuhtton 2018
    Viečča ollesdeavstta Viečča ollesdeavstta
    Artigo
    Lasit oiddohiidda
    Furkejuvvon:
  9. 9
    Human cytomegalovirus (HCMV) late-mRNA detection in peripheral blood of AIDS patients: diagnostic value for HCMV disease compared with those of viral culture and HCMV DNA detection

    Human cytomegalovirus (HCMV) late-mRNA detection in peripheral blood of AIDS patients: diagnostic value for HCMV disease compared with those of viral culture and HCMV DNA detection Dahkki Joël Gozlan, J.‐M. Salord, C. Chouaïd, Claudine Duvivier, O Picard, Marie‐Caroline Meyohas, Jean‐Claude Petit

    Almmustuhtton 1993
    Viečča ollesdeavstta Viečča ollesdeavstta
    Artigo
    Lasit oiddohiidda
    Furkejuvvon:
  10. 10
    Chronic bronchitis in the general population: Influence of age, gender and socio-economic conditions

    Chronic bronchitis in the general population: Influence of age, gender and socio-economic conditions Dahkki Alexis Ferré, C. Fuhrman, Mahmoud Zureik, C. Chouaïd, A. Vergnenègre, Gérard Huchon, Marie-Christine Delmas, Nicolás Roche

    Almmustuhtton 2011
    Viečča ollesdeavstta Viečča ollesdeavstta
    Artigo
    Lasit oiddohiidda
    Furkejuvvon:
  11. 11
    Anti-PD-(L)1 for KRAS-mutant advanced non-small–cell lung cancers: a meta-analysis of randomized–controlled trials

    Anti-PD-(L)1 for KRAS-mutant advanced non-small–cell lung cancers: a meta-analysis of randomized–controlled trials Dahkki Thierry Landre, G. Justeau, Jean‐Baptiste Assié, Kader Chouahnia, Claire Davoine, Chérifa Taleb, C. Chouaïd, Boris Duchemann

    Almmustuhtton 2021
    Viečča ollesdeavstta
    Revisão
    Lasit oiddohiidda
    Furkejuvvon:
  12. 12
    Infectious complications associated with the use of immune checkpoint inhibitors in oncology: reactivation of tuberculosis after anti PD-1 treatment

    Infectious complications associated with the use of immune checkpoint inhibitors in oncology: reactivation of tuberculosis after anti PD-1 treatment Dahkki H. Picchi, Christine Mateus, C. Chouaïd, Benjamin Besse, Aurélien Marabelle, Jean‐Marie Michot, Stéphane Champiat, Anne-Laure Voisin, Olivier Lambotte

    Almmustuhtton 2017
    Viečča ollesdeavstta Viečča ollesdeavstta
    Editorial
    Lasit oiddohiidda
    Furkejuvvon:
  13. 13
    The association between asthma control, health care costs, and quality of life in France and Spain

    The association between asthma control, health care costs, and quality of life in France and Spain Dahkki Marianne Doz, C. Chouaïd, Laure Com-Ruelle, Eduardo Calvo, Max Brosa, J. Robert, L. Decuypère, C. Pribil, Alicia Huerta, B. Detournay

    Almmustuhtton 2013
    Viečča ollesdeavstta Viečča ollesdeavstta
    Artigo
    Lasit oiddohiidda
    Furkejuvvon:
  14. 14
    Effect of immunotherapy-infusion time of day on survival of patients with advanced cancers: a study-level meta-analysis

    Effect of immunotherapy-infusion time of day on survival of patients with advanced cancers: a study-level meta-analysis Dahkki Thierry Landre, Abdoulaye Karaboué, Zachary S. Buchwald, Pasquale F. Innominato, David C. Qian, Jean‐Baptiste Assié, C. Chouaïd, Françis Lévi, Boris Duchemann

    Almmustuhtton 2024
    Viečča ollesdeavstta Viečča ollesdeavstta
    Revisão
    Lasit oiddohiidda
    Furkejuvvon:
  15. 15
    Preclinical and Preliminary Clinical Activity of NVP-BKM120, an Oral Pan-Class I PI3K Inhibitor, in the Brain

    Preclinical and Preliminary Clinical Activity of NVP-BKM120, an Oral Pan-Class I PI3K Inhibitor, in the Brain Dahkki Michel Maira, Christian Schnell, Pier‐Luigi Lollini, C. Chouaïd, Peter Schmid, Paolo Nanni, Dawn Lam, Emmanuelle di Tomaso, Cristian Massacesi, Jordi Rodón

    Almmustuhtton 2012
    Viečča ollesdeavstta
    Artigo
    Lasit oiddohiidda
    Furkejuvvon:
  16. 16
    Epidemiology and Treatment Costs of Bone Metastases from Lung Cancer: A French Prospective, Observational, Multicenter Study (GFPC 0601)

    Epidemiology and Treatment Costs of Bone Metastases from Lung Cancer: A French Prospective, Observational, Multicenter Study (GFPC 0601) Dahkki C. Decroisette, I. Monnet, H. Bérard, Gilles Quéré, H. Le Caer, Suzanna Bota, Clarisse Audigier-Valette, L. Gérinière, Jean-Marc Vernejoux, C. Chouaïd

    Almmustuhtton 2011
    Viečča ollesdeavstta
    Artigo
    Lasit oiddohiidda
    Furkejuvvon:
  17. 17
    Multicentre phase II study of cisplatin–etoposide chemotherapy for advanced large-cell neuroendocrine lung carcinoma: the GFPC 0302 study

    Multicentre phase II study of cisplatin–etoposide chemotherapy for advanced large-cell neuroendocrine lung carcinoma: the GFPC 0302 study Dahkki J. Le Treut, M. C. Sault, H. Léna, P.-J. Souquet, A. Vergnenègre, H. Le Caer, H. Bérard, S. Boffa, I. Monnet, Diane Damotte, C. Chouaïd

    Almmustuhtton 2013
    Viečča ollesdeavstta Viečča ollesdeavstta
    Artigo
    Lasit oiddohiidda
    Furkejuvvon:
  18. 18
    Safety of combined PD‐1 pathway inhibition and radiation therapy for non‐small‐cell lung cancer: A multicentric retrospective study from the GFPC

    Safety of combined PD‐1 pathway inhibition and radiation therapy for non‐small‐cell lung cancer: A multicentric retrospective study from the GFPC Dahkki Paul Lesueur, Alexandre Escande, Juliette Thariat, E. Vauléon, I. Monnet, Alexis B. Cortot, D. Lerouge, S. Danhier, Pascal Dô, Catherine Dubos‐Arvis, C. Chouaïd, Radj Gervais

    Almmustuhtton 2018
    Viečča ollesdeavstta Viečča ollesdeavstta
    Artigo
    Lasit oiddohiidda
    Furkejuvvon:
  19. 19
    Prognostic value of inflammatory response biomarkers using peripheral blood and [18F]-FDG PET/CT in advanced NSCLC patients treated with first-line chemo- or immunotherapy

    Prognostic value of inflammatory response biomarkers using peripheral blood and [18F]-FDG PET/CT in advanced NSCLC patients treated with first-line chemo- or immunotherapy Dahkki Romain-David Seban, Jean‐Baptiste Assié, Etienne Giroux‐Leprieur, Marie-Ange Massiani, G. Bonardel, C. Chouaïd, Nicolas Deleval, Capucine Richard, Laura Mezquita, Nicolas Girard, Laurence Champion

    Almmustuhtton 2021
    Viečča ollesdeavstta Viečča ollesdeavstta
    Artigo
    Lasit oiddohiidda
    Furkejuvvon:
  20. 20
    Immunotherapy rechallenge after nivolumab treatment in advanced non-small cell lung cancer in the real-world setting: A national data base analysis

    Immunotherapy rechallenge after nivolumab treatment in advanced non-small cell lung cancer in the real-world setting: A national data base analysis Dahkki Matteo Giaj Levra, François-Emery Cotté, R. Corre, C. Calvet, Anne-Françoise Gaudin, John R. Penrod, V. Grumberg, B. Jouaneton, R. Jolivel, Jean‐Baptiste Assié, C. Chouaïd

    Almmustuhtton 2019
    Viečča ollesdeavstta Viečča ollesdeavstta
    Artigo
    Lasit oiddohiidda
    Furkejuvvon:

Ohcanreaiddut: